These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 17661834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE, Scapini A, da Rosa Miltersteiner D, da Costa MG, Campos BM.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [Abstract] [Full Text] [Related]

  • 3. Accumulation of phosphatydilcholine-hydroperoxide in dialysis patients with diabetic nephropathy.
    Sanaka T, Takahashi C, Sanaka M, Higuchi C, Shinobe M, Hayasaka Y, Miyazawa T, Ishikawa S, Nihei H, Omori Y.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S33-7. PubMed ID: 8608660
    [Abstract] [Full Text] [Related]

  • 4. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
    García Ortiz R, Gómez M, Olea C.
    Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of glycemic status during the days of hemodialysis using dialysis solutions with and without glucose.
    Padmanabhan A, Velayudham B, Vijaykumar N, Allauddin S.
    Saudi J Kidney Dis Transpl; 2018 Dec; 29(5):1021-1027. PubMed ID: 30381496
    [Abstract] [Full Text] [Related]

  • 12. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
    Ersoy FF, Karayalcin U, Karayalcin B, Sapan M, Bozcuk H, Süleymanlar G, Yakupoglu G.
    Adv Perit Dial; 1995 Dec; 11():119-22. PubMed ID: 8534683
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial.
    Raimann JG, Kruse A, Thijssen S, Kuntsevich V, Dabel P, Bachar M, Diaz-Buxo JA, Levin NW, Kotanko P.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1559-68. PubMed ID: 21940484
    [Abstract] [Full Text] [Related]

  • 15. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
    Sombolos KI, Bamichas GI, Christidou FN, Gionanlis LD, Karagianni AC, Anagnostopoulos TC, Natse TA.
    Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL, Chiu YL, Lin JW, Chen SI, Wu KD.
    Blood Purif; 2008 Nov; 26(2):213-20. PubMed ID: 18285698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.